Profile
David Peritt worked as Director-Biosimilars Biology at Pfizer Inc. from 2015 to 2016 and as Chief Technology Officer at Sigilon Therapeutics, Inc. from 2017 to 2021.
He holds a doctorate degree from the University of Pennsylvania.
Former positions of David Peritt
| Companies | Position | End |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31/03/2021 |
| PFIZER, INC. | Corporate Officer/Principal | 31/12/2015 |
Training of David Peritt
| University of Pennsylvania | Doctorate Degree |
Experiences
Positions held
Connections
59
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| SIGILON THERAPEUTICS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
- Stock Market
- Insiders
- David Peritt
